InsidersTradesSigma
Track the 株式会社PALTAC stock price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are listed on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社PALTAC has logged 22 public disclosures. Market capitalisation: €575.9bn. The latest transaction was disclosed on 17 July 2026 (Holding update). Among the most active insiders: FMR LLC. The full history is free.
22
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 株式会社PALTAC Hold (neutral), based on 4 analysts. Average price target: JP¥2,963.
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,329 of 29,053 companies
55.8
score / 100
Value64
Quality48
FCF yld5.6%
Earn yld5.5%
EV/EBITDA10.6x
ROE7.3%
Gross mgn7.5%
Net mgn1.8%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 July 2026
Declarations22 total
33.71% mcap54.0% of flowShareXTKSEDINET:S100YR77
30.09% mcap100.0% of flowShareXTKSEDINET:S100YPWY
ShareXTKSEDINET:S100YDY8
ShareXTKSEDINET:S100YDY3
ShareXTKSEDINET:S100YDXV
ShareXTKSEDINET:S100YDXQ
ShareXTKSEDINET:S100YCPB
ShareXTKSEDINET:S100Y9ET
ShareXTKSEDINET:S100SBDI
ShareXTKSEDINET:S100QHP5
22 of 22 declarations
About 株式会社PALTAC
PALTAC Corporation is a Japanese company specializing in the distribution of health and pharmaceutical products. It primarily operates in the health market in Japan.